Clinical Trials on Food Habits in Russian Federation

Total 100 results

PepsiCo Global R&D

Completed

Assess Extent of Agreement Between Online 24-hr Dietary Recall and Interviewer-administered 24-hr Dietary Recall on the Same Day for 2 Non-consecutive 2 Days 1 wk Apart to Adults and School Age Children

Dietary Habits

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Collagen for Treatment of Musculoskeletal Injuries

Anterior Cruciate Ligament Injuries | Hallux Rigidus

Russian Federation
NovoNatum Ltd

Completed

Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns

Constipation | Gastro Esophageal Reflux | Infantile Colic | Infantile Diarrhea

Russian Federation
Human Stem Cell Institute, Russia
Ryazan State Medical University; Vidnoe District Hospital

Completed

Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot

Ulcers Related to Diabetic Foot Syndrome

Russian Federation
Russian Academy of Medical Sciences
Russian Science Foundation

Completed

Efficacy of Resveratrol in Depression

Depression

Russian Federation
Biotec Pharmacon ASA

Completed

Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients

Foot Ulcer

Russian Federation
Federal Research Center of Fundamental and Translational...

Completed

Real-time fMRI Neurofeedback for Mild/Moderate Depression

Depression Moderate | Depression Mild

Russian Federation
Moscow Research Institute of Psychiatry
Abbott

Completed

Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine

Recurrent Depressive Disorder

Russian Federation
Merz Pharmaceuticals GmbH
LLC Merz Pharma, Russia

Completed

Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy (XEBEC)

Cerebral Palsy | Spastic Paraplegia and Hemiparesis | Equine and Equinovarus Foot Deformation

Russian Federation
Federal Stare Budgetary Scientific Institution,...
Kazan State Medical University; Federal State Budgetary Institution V.M. Bekhterev...

Recruiting

Seroquel ® in Patients With Bipolar Disorder in Remission With Signs of Impaired Impulse Control

Bipolar Affective Disorder

Russian Federation
Servier Russia

Recruiting

Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR) (TELESPHOR)

Depression | COVID-19

Russian Federation
Moscow Psychiatric Hospital No. 1 Named after N...

Recruiting

Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia (RECATA)

Schizophrenia | Schizo Affective Disorder | Catatonia | Bipolar Affective Disorder

Russian Federation
Kalaco Scientific, Inc.

Completed

Nexalin Therapy for the Treatment of Depressive Symptoms

Depression

Russian Federation
AstraZeneca

Completed

Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression

Schizophrenia | Schizoaffective Disorder | Recurrent Depression

Russian Federation
Rovi Pharmaceuticals Laboratories

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

Foot Ulcer, Diabetic

Croatia, Poland, Romania, Russian Federation, Serbia, Spain
AstraZeneca

Completed

Retrospective Observational Study DIANA Study (DIANA)

Major Depressive Episode

Russian Federation
Eli Lilly and Company

Completed

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Bipolar Depression

Russian Federation, United States
Sanofi

Completed

An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (FIDELIO)

Major Depressive Disorder

Romania, Russian Federation, Ukraine, Mexico, Slovakia, Chile, South Africa
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation
GlaxoSmithKline

Terminated

A Study of GW856553X For the Treatment of Depression

Depressive Disorder, Major

India, Russian Federation, Estonia
National Institute of Mental Health (NIMH)

Completed

Neuropsychological Evaluation of Psychiatric and Neurological Patients

Schizophrenia | Seizures | Head Injury | Anxiety Disorder | Mood Disorder

United States, France, Russian Federation
Sanofi

Completed

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder (LENA)

Depressive Disorder

Canada, Russian Federation, Bulgaria, Mexico, Argentina, Chile, Croatia
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.

Depressive Disorder, Major

Russian Federation, Estonia
Sumitomo Pharma Co., Ltd.

Completed

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Bipolar Depression

Lithuania, Malaysia, Russian Federation, Slovakia, Ukraine, Japan, Philippines, Taiwan
Pfizer

Completed

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Diabetic Foot Ulcer

Canada, Austria, Czech Republic, Sweden, Russian Federation, Poland, Norway, United Kingdom, Italy, Belgium, Denmark, Germany, Greece, Ukraine
Sanofi

Completed

An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder

Depressive Disorder

United States, France, Russian Federation, Sweden, Turkey, Czech Republic, Mexico, Croatia
Sanofi

Completed

An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (COMPASS)

Depressive Disorder, Major

United States, Russian Federation, Germany, Estonia, Mexico, Korea, Republic of, Chile, South Africa
GlaxoSmithKline

Completed

Safety and Efficacy Study in Patients With Major Depressive Disorder

Depressive Disorder

Russian Federation
Abbott
Manipal Acunova Ltd.

Completed

Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder (FRIENDS)

Depression

Russian Federation
OcuNexus Therapeutics, Inc.

Completed

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE) (DUNE)

Diabetic Foot Ulcers

Russian Federation, United States, Ukraine
Sanofi

Completed

Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder

Major Depressive Disorders

Russian Federation, Spain, Singapore, Taiwan, Tunisia, Argentina, Chile, Hong Kong, Morocco, South Africa, Greece
Kuros Biosurgery AG

Completed

A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers (DFU)

Diabetic Foot Ulcer

Czech Republic, Germany, Hungary, Romania, Russian Federation, Serbia
GlaxoSmithKline

Completed

Major Depressive Disorder In The Elderly

Depressive Disorder, Major

Belgium, Australia, Russian Federation, Netherlands, Norway, Finland
Pfizer

Terminated

Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder

Depressive Disorder, Major

United States, Former Serbia and Montenegro, Russian Federation
Sanofi

Completed

A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder (CALYPSO)

Depressive Disorder | Major Depression

France, Poland, Romania, Russian Federation, Bulgaria, Serbia, Slovakia, Czech Republic, Mexico, Argentina, Croatia, Finland, South Africa
Pfizer

Completed

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Chile, United States, Estonia, Russian Federation
Sinovac Biotech Co., Ltd
Shandong Province Centers for Disease Control and Prevention

Completed

Immunogenicity and Safety of Two Different Commercial EV71 Vaccines

Hand, Foot and Mouth Disease

China
GlaxoSmithKline

Completed

Clinical Study to Test a New Drug to Treat Major Depression (PKI113009)

Depressive Disorder, Major

Bulgaria, United States, Germany, Russian Federation, Estonia
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study of Patients With Major Depressive Disorder and Residual Apathy

Major Depressive Disorder

Mexico, Russian Federation, Australia, Taiwan, Canada
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Slovakia, Poland, Hungary, Japan, Russian Federation
Janssen Research & Development, LLC

Completed

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Major Depressive Disorder

Ukraine, Bulgaria, Romania, Russian Federation, Hungary, Moldova, Republic of
H. Lundbeck A/S

Terminated

Vortioxetine to Prevent Return of Symptoms in Children With Depression

Depression

United States, Mexico, Russian Federation, Colombia, Latvia, Poland, Ukraine
Ipsen

Completed

Post Marketing Surveillance Study of Dysport

Cerebral Palsy | Cervical Dystonia | Muscle Spasticity | Cerebrovascular Accident | Equinus Deformity | Hemifacial Spasm | Blepharospasm | Spasmodic Torticollis | Facial Hyperdynamic Lines

France, Germany, Russian Federation
H. Lundbeck A/S

Completed

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Depressive Disorder, Major

Spain, Hungary, Russian Federation, Bulgaria, Estonia, France, Germany, Italy, Latvia, Poland, Serbia, South Africa, United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

Major Depressive Disorder

France, Italy, Russian Federation, South Africa
Pfizer

Completed

Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (FEENICS)

Diabetic Foot Ulcer

Canada, Greece, Austria, Finland, Poland, Sweden, Russian Federation, Norway, Spain, Italy, United Kingdom, Denmark, Lithuania, Belgium, Germany, Ukraine, Czechia
Institut de Recherches Internationales Servier
ADIR Association

Completed

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Major Depressive Disorder

Bulgaria, Czechia, Finland, Hungary, Russian Federation, Slovakia, Ukraine
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder

Depressive Disorder, Major

United States, France, Germany, Italy, Russian Federation, Sweden
Pfizer

Completed

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Depression | Smoking Cessation

Spain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Mood Disorders | Bipolar Disorder

United States, Taiwan, Russian Federation, Turkey, Ukraine, Greece, Korea, Republic of, Lithuania

Clinical Trials on Food Habits in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations